Hamer MJ, Houser KV, Hofstetter AR, Ortega-Villa AM, et al. Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial. Lancet 2023;401:294-302.
PMID: 36709074